KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.7 million.

  • Idexx Laboratories' Non-Current Deferred Tax Liability fell 3418.17% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 3418.17%. This contributed to the annual value of $11.3 million for FY2024, which is 8984.01% down from last year.
  • Latest data reveals that Idexx Laboratories reported Non-Current Deferred Tax Liability of $3.7 million as of Q3 2025, which was down 3418.17% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability ranged from a high of $111.3 million in Q4 2023 and a low of $2.1 million during Q2 2025
  • Over the past 5 years, Idexx Laboratories' median Non-Current Deferred Tax Liability value was $10.6 million (recorded in 2023), while the average stood at $24.7 million.
  • Examining YoY changes over the last 5 years, Idexx Laboratories' Non-Current Deferred Tax Liability showed a top increase of 8001.08% in 2024 and a maximum decrease of 8984.01% in 2024.
  • Quarter analysis of 5 years shows Idexx Laboratories' Non-Current Deferred Tax Liability stood at $106.7 million in 2021, then fell by 8.77% to $97.3 million in 2022, then increased by 14.38% to $111.3 million in 2023, then crashed by 89.84% to $11.3 million in 2024, then tumbled by 67.08% to $3.7 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $3.7 million for Q3 2025, versus $2.1 million for Q2 2025 and $8.1 million for Q1 2025.